From: Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study
Symptoms | Total | |
---|---|---|
(n = 288) | CI95% | |
Difficulty in breathing (Dyspnoea) | 223 (77.4%) | 72.2–82.1 |
Fever | 199 (69.1%) | 63.4–74.4 |
Cough | 196 (68.1%) | 62.3–73.4 |
Fatigue | 196 (68.1%) | 62.3–73.4 |
Drop in oxygen saturation | 165 (57.3%) | 51.4–63.1 |
Chills | 119 (41.3%) | 35.6–47.3 |
Diarrheia | 111 (38.5%) | 32.9–44.4 |
Joint pains | 103 (35.8%) | 30.2–41.6 |
Sore throat | 103 (35.8%) | 30.2–41.6 |
Stuffy nose | 99 (34.4%) | 28.9–40.2 |
Tight chest | 99 (34.4%) | 28.9–40.2 |
Nausea | 94 (32.6%) | 27.3–38.4 |
Abdominal pain | 70 (24.3%) | 19.5–29.7 |
Vomiting | 67 (23.3%) | 18.5–28.6 |
Cyanosis | 25 (8.7%) | 5.7–12.6 |
NEUROLOGICAL SYMPTOMS | ||
Any neurological symptom | 264 (91.7%) | 87.9–94.6 |
Hypogeusia/ageusia | 201 (69.8%) | 64.1–75 |
Headache | 199 (69.1%) | 63.4–74.4 |
Hyposmia/anosmia | 193 (67.0%) | 61.3–72.4 |
Myalgia | 128 (44.4%) | 38.6–50.4 |
Drowsiness | 107 (37.2%) | 31.6–43 |
Agitation | 60 (20.8%) | 16.3–26 |
Mental confusion | 43 (14.9%) | 11–19.6 |
Syncope | 14 (4.9%) | 2.7–8 |
Epileptic seizure | 8 (2.8%) | 1.2–5.4 |